Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma?a comparison between L-TAE with Farmorubicin and L-TAE with Adriamycin: preliminary results (second cooperative study)
- 1 January 1994
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 33 (1), S97-S102
- https://doi.org/10.1007/bf00686677
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Chemoembolization of hepatocellular carcinomas a study of the biodistribution and pharmacokinetics of doxorubicinCancer, 1992
- Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma ? a comparison of L-TAE with Farmorubicin and L-TAE with Adriamycin (second cooperative study)Cancer Chemotherapy and Pharmacology, 1992
- Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma ? a comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study)Cancer Chemotherapy and Pharmacology, 1992
- Cardiotoxicity of epirubicin and doxorubicin: A double‐blind randomized studyEuropean Journal of Haematology, 1991
- The general rules for the clinical and pathological study of primary liver cancerSurgery Today, 1989